Since 1998, OCRA has awarded 349 grants and invested over $100 million in ovarian cancer research from top scientists at 79 leading medical centers. We invest our dollars wisely, supporting the best ovarian cancer research in the nation.

OCRA-funded projects have led to significant advances in such areas as early detection, diagnosis, genetics, prevention, treatments, and enhancing quality of life.

In just the past year, OCRA-funded researchers have:

The results of OCRA-supported research projects have been published in some of the world’s most prestigious journals, such as: Gynecologic Oncology, Lancet Oncology, New England Journal of Medicine, Cancer Research, Clinical Cancer Research, Journal of Clinical Oncology, Science Translational Medicine, Cancer Discovery and Nature.